Drug Type Autologous CAR-T |
Synonyms GPC3-Targeted Chimeric Antigen Receptor Autologous T-Cell |
Target |
Action modulators |
Mechanism GPC3 modulators(Glypican-3 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Hepatocellular Carcinoma | Phase 1 | China | 27 Mar 2026 | |
| GPC3 Positive Hepatocellular Carcinoma | Phase 1 | China | 27 Mar 2026 |





